Latest filing published 02 Oct 2013 for WATSON PHARMACEUTICALS INC.
No signal scores available.
Filings by Michael J. Fedida span 2 companies, the busiest being Watson Pharmaceuticals Inc and Bradley Pharmaceuticals Inc. Over a trading history stretching from 5 May 2006 to 1 October 2013, the count stands at 28 filings.
No open-market purchase appears, only 8 sales worth €2.1M. Outside the open market, there are 8 share grants and 4 option exercises. In 2013 alone, the filings show no purchases and 1 sale.
The record was last updated on 2 October 2013 with a transaction in Watson Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
23 of 23 declarations